3rd Quarter - Report — GENENTECH, INC for GENENTECH INC (2009)

Firm

GENENTECH, INC

Client

GENENTECH INC

Income

—

Expenses

$630,000

Expense method

A: Lobbying Disclosure Act definitions

What was lobbied

7 issue areas, each in the filer's own words, with who lobbied on it and where.

Taxation/Internal Revenue Code TAX

General tax issues and tax extenders

Lobbyist	Covered position, as disclosed
DAVID B BURT	—
WALTER MOORE	—
PETER JOSEPH MULLER	—
HEIDI L WAGNER	—

Contacted: HOUSE OF REPRESENTATIVES; Centers For Medicare and Medicaid Services (CMS); Executive Office of the President (EOP); Health & Human Services, Dept of (HHS); SENATE

Copyright/Patent/Trademark CPT

H.R. 1260 Patent Reform S. 515 Patent Reform S. 610 Patent Reform H. R. 1909 Intellectual Property and Process Patent Issues S. 1145/H.R. 1908; Patent Reform Act of 2007 S. 623 Access to Life-Saving Medicine Act H.R. 5629 Pathways and Biosimilars Act

Lobbyist	Covered position, as disclosed
DAVID B BURT	—
WALTER MOORE	—
PETER JOSEPH MULLER	—
HEIDI L WAGNER	—

Contacted: Executive Office of the President (EOP); Health & Human Services, Dept of (HHS); HOUSE OF REPRESENTATIVES; Centers For Medicare and Medicaid Services (CMS); SENATE

Bills named: H.R. 1909 (111th), H.R. 1260 (111th), H.R. 5629 (111th), S. 610 (111th), H.R. 1908 (111th), S. 1145 (111th), S. 515 (111th), S. 623 (111th)

Health Issues HCR

Kennedy American Affordable Health Choices Act of 2009 H.R. 3200 American Affordable Health Choices Act of 2009 Tri Caucus Healthcare Reform Bill Baucus/Finance healthcare Reform Bill - America's Healthy Future Act of 2009 S. 1110 Medicare Payment Advisory Commission (MedPAC) Reform Act of 2009 H.R. 2502 Comparative Effectiveness Research Act of 2009 S. 1213 Patient-Centered Outcomes Research Act of 2009 S. 301 Physican Payments Sunshine Act of 2009 Senate Finance Committee Chairman's Mark, America's Healthy Future Act H.R. 1548 The Pathway to Biosimilars Act S. 726/H.R. 1427 Promoting Innovation and Access to Life Saving Medicines Act H.R. 1, The American Recovery and Reinvestment Act

Lobbyist	Covered position, as disclosed
DAVID B BURT	—
WALTER MOORE	—
PETER JOSEPH MULLER	—
HEIDI L WAGNER	—

Contacted: Health & Human Services, Dept of (HHS); Centers For Medicare and Medicaid Services (CMS); SENATE; HOUSE OF REPRESENTATIVES; Executive Office of the President (EOP)

Bills named: H.R. 3200 (111th), H.R. 1 (111th), S. 301 (111th), S. 1213 (111th), S. 726 (111th), H.R. 1548 (111th), H.R. 2502 (111th), H.R. 1427 (111th), S. 1110 (111th)

Medicare/Medicaid MMM

Medicare Issues Comparative Effectiveness S. 301 Physician Payments Sunshine Act of 2009 H.R. 2939 Oncology Quality Care Improvement Act Kennedy American Affordable Health Choices Act of 2009 H.R. 3200 American Affordable Health Choices Act of 2009 Tri Caucus Healthcare Reform Bill Baucus/Finance Healthcare Reform Bill - America's health future Act of 2009 S. 1110 Medicare Payment Advisory Commission (MedPAC) Reform Act of 2009 H.R. 2502 Comparative Effectiveness Research Act of 2009 S. 1213 Patient-Centered Outcomes Research Act of 2009 Senate Finance Committee Chairman's Mark, America's Healthy Future Act S. 266 Medicare Prescription Drug Gap Reduction Act of 2009 S. 330/H.R. 684 Medicare prescription Drug Savings and Choice Act of 2009

Lobbyist	Covered position, as disclosed
DAVID B BURT	—
WALTER MOORE	—
PETER JOSEPH MULLER	—
HEIDI L WAGNER	—

Contacted: SENATE; HOUSE OF REPRESENTATIVES; Health & Human Services, Dept of (HHS); Centers For Medicare and Medicaid Services (CMS); Executive Office of the President (EOP)

Bills named: H.R. 3200 (111th), S. 266 (111th), S. 1110 (111th), S. 301 (111th), S. 1213 (111th), H.R. 684 (111th), H.R. 2502 (111th), S. 330 (111th), H.R. 2939 (111th)

Budget/Appropriations BUD

H.R. 1 American Recovery and Reinvestment Act of 2009 S. Con. Res. 13 H. Con. Res. 85 Comparative Effectiveness

Lobbyist	Covered position, as disclosed
DAVID B BURT	—
WALTER MOORE	—
PETER JOSEPH MULLER	—
HEIDI L WAGNER	—

Contacted: SENATE; Health & Human Services, Dept of (HHS); HOUSE OF REPRESENTATIVES; Centers For Medicare and Medicaid Services (CMS); Executive Office of the President (EOP)

Bills named: H.Con.Res. 85 (111th), H.R. 1 (111th), S.Con.Res. 13 (111th)

Pharmacy PHA

H.R. 1427 Promoting Innovation and Access to Life-Saving Medicine Act H.R. 1548 Pathway for Biosimilars Act of 2009 S. 726 Promoting INnovation and Access to Life-Saving Medicine Act H.R. 3200, America's Affordable Health Choices Act S. 1679, the Affordable Health Choices Act Senate Finance committee Chairman's Mark, America's health Future Act S. 1232, the Pharmaceutical Market Access and Drug Safety Act

Lobbyist	Covered position, as disclosed
DAVID B BURT	—
WALTER MOORE	—
PETER JOSEPH MULLER	—
HEIDI L WAGNER	—

Contacted: Executive Office of the President (EOP); HOUSE OF REPRESENTATIVES; Centers For Medicare and Medicaid Services (CMS); SENATE; Health & Human Services, Dept of (HHS)

Bills named: S. 1679 (111th), H.R. 1548 (111th), S. 1232 (111th), H.R. 3200 (111th), S. 726 (111th), H.R. 1427 (111th)

Medical/Disease Research/Clinical Labs MED

LHHS Appropriations (CMS and comparative effectiveness related matters) Public Law 111-5, the American Recovery and Reinvestment Act of 2009 S. 1213, the Patient-Centered outcomes Research Act of 2009 H.R. 3200, America's Affordable Health Choices Act of 2009 Senate Finance Committee Chariman's Mark, America's Healthy Future Act

Lobbyist	Covered position, as disclosed
DAVID B BURT	—
WALTER MOORE	—
PETER JOSEPH MULLER	—
HEIDI L WAGNER	—

Contacted: Centers For Medicare and Medicaid Services (CMS); HOUSE OF REPRESENTATIVES; Health & Human Services, Dept of (HHS); SENATE; Executive Office of the President (EOP)

Bills named: S. 1213 (111th), H.R. 3200 (111th)

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.